Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs

Showing results (181-190 of 294) with videos related to

Pageof 30
Sort By:
Atherosclerosis|November 1, 2005
C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003S Matthijs Boekholdt, C Erik Hack, Manjinder S Sandhu, et al.
Circulation|May 16, 2013
High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effectJohannes A N Dorresteijn, S Matthijs Boekholdt, Yolanda van der Graaf, et al.
International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
Pre-procedural virtual reality education reduces anxiety in patients undergoing atrial septal closure - Results from a randomized trialMarinka D Oudkerk Pool, Jean-Luc Q Hooglugt, Anke J Kraaijeveld, et al.
European Journal of Preventive Cardiology|October 4, 2023
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohortTinka J van Trier, Marjolein Snaterse, S Matthijs Boekholdt, et al.
Journal of the American College of Cardiology|February 6, 2007
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyKarim El Harchaoui, Wim A van der Steeg, Erik S G Stroes, et al.
Pharmacogenetics and Genomics|July 31, 2010
Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary interventionMarcel A M Beijk, S Matthijs Boekholdt, Saskia Z H Rittersma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 2010
Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery diseaseDiederik F van Wijk, Sander I van Leuven, Manjinder S Sandhu, et al.
Atherosclerosis|May 15, 2010
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVTMenno Vergeer, Danny M Cohn, S Matthijs Boekholdt, et al.
European Heart Journal Open|September 4, 2025
Fuelling aortic stenosis: the integral role of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3-mediated glycolysis in Lp(a)-induced valve inflammationMerel Peletier, Lubna Ali, Kim Dzobo, et al.
Annals of Internal Medicine|January 21, 2009
High-density lipoprotein particle size and concentration and coronary riskKarim El Harchaoui, Benoit J Arsenault, Remco Franssen, et al.
Pageof 30

Showing results (181-190 of 294) with videos related to

Sort By:
Pageof 30
Atherosclerosis|November 1, 2005
C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003S Matthijs Boekholdt, C Erik Hack, Manjinder S Sandhu, et al.
Circulation|May 16, 2013
High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effectJohannes A N Dorresteijn, S Matthijs Boekholdt, Yolanda van der Graaf, et al.
International Journal of Cardiology. Congenital Heart Disease|December 23, 2024
Pre-procedural virtual reality education reduces anxiety in patients undergoing atrial septal closure - Results from a randomized trialMarinka D Oudkerk Pool, Jean-Luc Q Hooglugt, Anke J Kraaijeveld, et al.
European Journal of Preventive Cardiology|October 4, 2023
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohortTinka J van Trier, Marjolein Snaterse, S Matthijs Boekholdt, et al.
Journal of the American College of Cardiology|February 6, 2007
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyKarim El Harchaoui, Wim A van der Steeg, Erik S G Stroes, et al.
Pharmacogenetics and Genomics|July 31, 2010
Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary interventionMarcel A M Beijk, S Matthijs Boekholdt, Saskia Z H Rittersma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 2010
Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery diseaseDiederik F van Wijk, Sander I van Leuven, Manjinder S Sandhu, et al.
Atherosclerosis|May 15, 2010
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVTMenno Vergeer, Danny M Cohn, S Matthijs Boekholdt, et al.
European Heart Journal Open|September 4, 2025
Fuelling aortic stenosis: the integral role of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3-mediated glycolysis in Lp(a)-induced valve inflammationMerel Peletier, Lubna Ali, Kim Dzobo, et al.
Annals of Internal Medicine|January 21, 2009
High-density lipoprotein particle size and concentration and coronary riskKarim El Harchaoui, Benoit J Arsenault, Remco Franssen, et al.
Pageof 30